Trending topics from trusted journalism, transformed into structured debates. Unlike our community discussions, these are automatically curated from breaking news to spark timely, nuanced conversation.
News Discussions are automatically generated from trending stories in real-time. Explore Discussions shows community-created topics on any subject. Both use the same structured debate format, but News focuses on current affairs.
We aggregate stories from these reputable sources to ensure balanced, quality coverage:
Nature, Published online: 22 May 2026; doi:10.1038/d41586-026-01660-z Nature staff discuss ongoing efforts to curb the Bundibugyo virus outbreak
The Cabinet has greenlit a health care draft law designed to lower insurance rates. The bill heads to parliament next, but doctors' associations and patient protection advocates say it amounts to austerity measures
Mifepristone, involved in most abortions in the U.S., can now be distributed only in person and at clinics
The Offline piece1 by Richard Horton is right that global health is on the brink: funding is collapsing, political volatility persists unabated, and powerful actors are renegotiating international engagement. But the answer is not simply a new narrative organised around climate, pandemics, conflict, migration, demography, or digital transformation. What global health requires is structural reorientation
The AI model analyzes subtle tissue changes on routine CT scans invisible to human specialists, detecting pancreatic cancer up to three years earlier than doctors can
This brief describes how proposed expansions to eligibility for the Veterans Affairs Community Care program could affect New York veterans’ geographic access to care, timeliness of care, and quality of care
“For the first time, FDA regulators will be able to see what’s happening in a clinical trial, looking at endpoints in the cloud as they occur,” writes FDA commissioner
A Bill to place a duty on the Secretary of State to review, and publish a report on, the merits of increasing the relevant statutory sum under the Vaccine Damage Payments Act 1979 for all claims since 1 January 2020 by an amount representing the amount of inflation since 2007
Sen. Bernie Moreno (R-Ohio) isn't giving up on a health care plan that can win 35 Senate Republicans and a majority of Democrats — but he and a small bipartisan group have about three weeks left to find it. Why it matters: Enhanced ACA subsidies have expired, which will raise health care costs for millions of Americans. But key negotiators see a final chance to revive them. "We're on the clock," Moreno told Axios in an interview. "We're not going to talk about this past January — like, we either make a deal this month or we don't make a deal.""It may be we don't make a deal," he acknowledged, given the political atmosphere. He won't push a bill that only gets a handful of Republicans — he wants 35. Zoom in: The bipartisan plan would reinstate the ACA enhanced subsides for two years and extend open enrollment into March, Moreno said, walking through policies that he says have "decent consensus." It will likely include income caps at 700% of the poverty line, replace $0 premium plans with $5 premiums and allow individuals to choose whether the enhanced subsidies go into Health Savings Accounts or directly toward premiums.The group has also discussed massive penalties on insurance companies that deliberately enroll people into Obamacare without their knowledge. What to watch: Cost-sharing reductions are a big part of the talks now too, and would likely go into effect in year two, Moreno said. It could be key for GOP support as they cut government costs and, Moreno argued, would lower Obamacare premiums for everyone by about 11%. The other side: Language ensuring taxpayer dollars do not go toward abortions continues to be sticking point, Moreno acknowledged, though he hopes there can be a break through. "It's not about gaining ground and saying we're doing something more than [the Hyde Amendment]. And it's not something, on the Democrat side, saying we're doing something less than Hyde," he said. "We're trying to respect a established tradition."Trump urged House Republ
This document describes strategies to strengthen the process of sharing and applying emerging knowledge on patient care before and during public health emergencies, focusing on strategies that leaders of professional societies can use
We read with interest the results of the HARMONi-6 trial by Zhiwei Chen and colleagues,1 which showed that ivonescimab plus chemotherapy improved progression-free survival versus tislelizumab plus chemotherapy in advanced squamous non-small-cell lung cancer (NSCLC). However, PD-L1-based subgroup results reveal a critical stratification signal. In patients with PD-L1 tumour proportion score (TPS) of under 50%, dual blockade achieved marked benefit (hazard ratio [HR] 0·63; 95% CI 0·41–0·98), whereas in patients with PD-L1 TPS of 50% or over, the improvement was numerical but not significant (HR 0·71; 0·37–1·33)